Head-To-Head Contrast: Mobia Medical (NASDAQ:MOBI) and Organigram Global (NASDAQ:OGI)

Mobia Medical (NASDAQ:MOBI) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations.

Valuation & Earnings

This table compares Mobia Medical and Organigram Global”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobia Medical	$32.04 million	12.14	-$46.50 million	($19.30)	-0.61
Organigram Global	$185.07 million	0.96	-$17.70 million	($0.13)	-9.69

Organigram Global has higher revenue and earnings than Mobia Medical. Organigram Global is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

34.6% of Organigram Global shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Mobia Medical and Organigram Global, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobia Medical	1	1	5	0	2.57
Organigram Global	1	0	2	0	2.33

Mobia Medical presently has a consensus price target of $20.75, indicating a potential upside of 77.65%. Given Mobia Medical’s stronger consensus rating and higher probable upside, equities analysts plainly believe Mobia Medical is more favorable than Organigram Global.

Profitability

This table compares Mobia Medical and Organigram Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mobia Medical	N/A	N/A	N/A
Organigram Global	28.14%	-14.52%	-9.81%

Summary

Organigram Global beats Mobia Medical on 7 of the 13 factors compared between the two stocks.

About Mobia Medical

Mobia Medical Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc. is based in AUSTIN, Texas.

About Organigram Global

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.